富血小板血浆在髌骨外侧高压症治疗中的应用*

doi:10.3969/j.issn.1671-2587.2023.03.010

临床输血与检验 ›› 2023, Vol. 25 ›› Issue (3): 348-353.DOI: 10.3969/j.issn.1671-2587.2023.03.010

富血小板血浆在髌骨外侧高压症治疗中的应用^*

张强, 岳宪虎, 李瑞, 黄象艳

250031 中国人民解放军联勤保障部队第九六〇医院骨科（张强,岳宪虎,李瑞）; 中国人民解放军联勤保障部队第九六〇医院输血医学科（黄象艳）

收稿日期:2023-03-20 发布日期:2023-07-10
通讯作者: 黄象艳,主任技师,博士,主要从事输血检验和临床输血相关研究,（E-mail） xiangyan73@aliyun.com。
作者简介:张强,主任医师,博士,主要从事关节镜与运动医学方面的研究,（E-mail）zhangqiang7303@126.com。
基金资助:
^*本课题受山东省济南市临床医学科技创新计划（No.202225073）资助

Platelet-rich Plasma as a Treatment for Lateral Patellar Compression Syndrome

ZHANG Qiang, YUE Xianhu, LI Rui, et al

Department of Orthopaedics, the 960th Hospital of the PLA Joint Logistice Support Force, Jinan, Shandong 250031

Received:2023-03-20 Published:2023-07-10

摘要/Abstract

摘要： 目的研究单采自体富血小板血浆（platelet-rich plasma, PRP）联合外侧支持带松解（lateral retinacular release, LRR）治疗髌骨外侧高压症（lateral patellar compression syndrome, LPCS）的临床疗效。方法回顾性分析2018年8月—2021年4月在我院骨科治疗的符合纳入标准的髌骨外侧高压症患者15例（22膝）,分为试验组和对照组。试验组行关节镜下LRR术,术后予以单采自体PRP关节腔注射（单膝注射剂量5 mL,7天注射1次,3次为一个疗程）;对照组仅行关节镜下LRR术。采用视觉模拟评分法（VAS）、髌股关节Kujala评分法对不同治疗方法的治疗效果进行比较。通过MRI影像学进一步评估试验组的治疗效果。结果随访时间12~13（12.4±0.5）月。手术前后VAS评分结果：试验组分别为5.64±0.54,1.46±0.28;对照组分别为5.46±0.37,2.55±0.28。试验组Kujala评分从手术前的61.09±4.40增加到手术后的90.73±1.94;对照组Kujala评分从手术前的66.82±3.84增加到手术后的82.82±2.53。两组患者术后膝关节疼痛症状及髌股关节功能评分均较术前显著改善（P<0.000 1）,而且试验组VAS评分和Kujala评分优于对照组（P<0.05）。MRI随访显示,试验组治疗后髌骨及股骨外髁骨髓水肿的容积减小。结论单采自体PRP关节腔注射联合LRR是治疗LPCS的有效手段。

关键词: 髌骨外侧高压症, 外侧支持带松解, 血细胞分离单采, 富血小板血浆

Abstract: Objective To explore the clinical efficacy of autologous apheresis platelet-rich plasma (PRP) combined with lateral retinacular release (LRR) for the treatment of lateral patellar compression syndrome (LPCS). Methods A total of 15 patients (22 knees) with LPCS who met the inclusion criteria from August 2018 to April 2021 were retrospectively analyzed. They were divided into the experimental group and the control group. The experimental group underwent arthroscopic LRR surgery, followed by intra-articular injection of autologous PRP (5 mL injection per knee, once every 7 days, 3 times as a course). The control group only underwent arthroscopic LRR surgery. Visual analog scale (VAS) and Kujala score were used to compare the therapeutic effects. The therapeutic effect of the experimental group was further evaluated by MRI imaging. Results The follow-up time was 12~13 (12.4±0.5) months. VAS score before and after operation was 5.64±0.54 and 1.46 ±0.28 in the experimental group, respectively, 5.46±0.37 and 2.55±0.28 in the control group. Kujala score increased from 61.09±4.40 to 90.73±1.94 in the experimental group. Kujala score increased from 66.82±3.84 to 82.82±2.53 in the control group. Postoperative knee pain symptoms and patellofemoral joint function scores of both groups were significantly improved compared with those before surgery (P<0.000 1), and VAS score and Kujala score in the experimental group were better than those in the control group (P<0.05). MRI follow-up showed that the volume of bone marrow edema of the patella and external condyle in the experimental group reduced after treatment. Conclusion Intra-articular injection of autologous apheresis PRP combined with LRR is an effective method for the treatment of LPCS.

Key words: Lateral patellar compression, Lateral retinacular release, Apheresis, Platelet-rich plasma

中图分类号:

R874.5

张强, 岳宪虎, 李瑞, 黄象艳. 富血小板血浆在髌骨外侧高压症治疗中的应用^*[J]. 临床输血与检验, 2023, 25(3): 348-353.

ZHANG Qiang, YUE Xianhu, LI Rui, et al. Platelet-rich Plasma as a Treatment for Lateral Patellar Compression Syndrome[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 348-353.

参考文献

[1] SMITH B E,SELFE J,THACKER D,et al.Incidence and prevalence of patellofemoral pain:a systematic review and meta-analysis[J].PLoS One,2018,13(1):e0190892.
[2] CLIFTON R,NG C Y,NUTTON R W.What is the role of lateral retinacular release?[J].J Bone Jt Surg Br Vol,2010,92-B(1):1-6.
[3] SZWEDOWSKI D,MOBASHERI A,MONIUSZKO A,et al.Intra-articular injection of platelet-rich plasma is more effective than hyaluronic acid or steroid injection in the treatment of mild to moderate knee osteoarthritis:a prospective,randomized,triple-parallel clinical trial[J].Biomedicines,2022,10(5):991.
[4] 魏燕,刘宽,李祥军,等.PRP治疗踝关节创伤性滑膜炎疗效观察[J].临床输血与检验,2022,24(6):725-730.
[5] CHEN J B,CHEN D,XIAO Y P,et al.Efficacy and experience of arthroscopic lateral patella retinaculum releasing through/outside synovial membrane for the treatment of lateral patellar compression syndrome[J].BMC Musculoskelet Disord,2020,21(1):108.
[6] FELLI L,FORMICA M,LOVISOLO S,et al.Clinical outcome of arthroscopic lateral retinacular release for symptomatic bipartite Patella in athletes[J].Arthroscopy,2018,34(5):1550-1558.
[7] 庞成龙,颜世昌,陈晖.富血小板血浆治疗膝骨性关节炎的研究进展[J].骨科,2019,10(2):167-172.
[8] COOK C S,SMITH P A.Clinical update:why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee[J].Curr Rev Musculoskelet Med,2018,11(4):583-592.
[9] DI MARTINO A,DI MATTEO B,PAPIO T,et al.Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis:results at 5 years of a double-blind,randomized controlled trial[J].Am J Sports Med,2018,47:347-354.
[10] SU K,BAI Y M,WANG J,et al.Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis[J].Clin Rheumatol,2018,37(5):1341-1350.
[11] RAEISSADAT SA, GHAZI HOSSEINI P, BAHRAMI MH, et al.The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial[J].BMC Musculoskelet Disord,2021,22(1):134.
[12] COLLINS T, ALEXANDER D, BARKATALI B.Platelet-rich plasma: a narrative review[J]. EFORT Open Rev,2021,6(4):225-235.
[13] MELNIKOV D V,KIRILLOVA K A,ZAKHARENKO A S,et al.Effect of cryo-processing on platelet-rich autoplasma preparations[J].Sovrem Tekhnologii Med,2021,12(6):54-60.
[14] YAO W W,QU N,YANG S X,et al.Quantitative evaluation in combination with nonquantitative evaluation in early patellar cartilage osteoarthritis at 3.0 T[J].Clin Interv Aging,2014:1133.
[15] EHLERS C B,WEBB A R,MCCORMICK B P,et al.Standardized platelet rich plasma injections for osteoarthritis of the knee[J].Cureus,2020,12(10):e10900.
[16] EYMARD F,ORNETTI P,MAILLET J,et al.Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis:a consensus statement from French-speaking experts[J].Knee Surg Sports Traumatol Arthrosc,2021,29(10):3195-3210.
[17] 中国输血协会临床输血管理学专业委员会.自体富血小板血浆制备技术专家共识[J].中国输血杂志,2021,34(7):677-683.
[18] QIAO J,AN N,OUYANG X Y.Quantification of growth factors in different platelet concentrates[J].Platelets,2017,28(8):774-778.

富血小板血浆在髌骨外侧高压症治疗中的应用^*

Platelet-rich Plasma as a Treatment for Lateral Patellar Compression Syndrome

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	中国输血协会临床输血管理学专业委员会. 自体单采富血小板血浆治疗薄型子宫内膜的专家共识[J]. 临床输血与检验, 2023, 25(3): 289-296.
[2]	刘琴, 沈先涛, 徐春芬, 王阳, 杨柳春, 胡红兵. 自体富血小板血浆治疗儿童病理性骨折疗效观察^*[J]. 临床输血与检验, 2023, 25(3): 354-357.
[3]	巩蜜蜜, 汪海宁, 吴磊, 邵小宝, 周琳, 杨圆, 王华, 高凤威, 戴宇东, 朱培元. 同种异体富血小板血浆用于慢性难愈性创面的临床研究^*[J]. 临床输血与检验, 2023, 25(3): 368-374.
[4]	毛平平, 王淑君, 罗开云, 齐清, 赵广超, 栾建凤. 冰冻PRP和冻干PRP的抗菌作用研究^*[J]. 临床输血与检验, 2022, 24(6): 705-709.
[5]	魏燕, 刘宽, 李祥军, 彭娟, 王瑞含, 刘久波. PRP治疗踝关节创伤性滑膜炎疗效观察^*[J]. 临床输血与检验, 2022, 24(6): 725-729.
[6]	罗开云, 王淑君, 毛平平, 孙杨子, 齐清, 栾建凤. 不同保存方式对PRP相关生长因子影响的研究*[J]. 临床输血与检验, 2022, 24(1): 70-73.
[7]	杨菁, 周谋, 林放, 施琳颖, 李艳辉, 李文丹, 单桂秋. 负载PRP壳聚糖-明胶复合敷料止血和促愈合效果的初步评价^*[J]. 临床输血与检验, 2021, 23(5): 612-616.
[8]	杨晓亚, 高裕华, 刘素蕊, 李烛. 冰冻保存PRP对IL-1β诱导的软骨细胞炎症反应的影响[J]. 临床输血与检验, 2021, 23(4): 442-445.
[9]	林放, 周谋, 单桂秋, 李艳辉, 李文丹. 不同来源复水液对冻干PRP活化和释放生长因子影响的比较^*[J]. 临床输血与检验, 2021, 23(2): 142-145.
[10]	王瑞含, 范金波, 周国均, 王飞, 刘久波. PRP治疗膝骨关节炎的临床应用研究进展[J]. 临床输血与检验, 2020, 22(6): 659-663.
[11]	王淑君, 赵广超, 栾建凤, 朱培元. 不同规格全血制备富血小板血浆的最佳离心条件研究^*[J]. 临床输血与检验, 2017, 19(2): 119-122.